GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangxi Xinganjiang Pharmaceutical Co Ltd (BJSE:873167) » Definitions » Total Stockholders Equity

Jiangxi Xinganjiang Pharmaceutical Co (BJSE:873167) Total Stockholders Equity : ¥473.9 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Jiangxi Xinganjiang Pharmaceutical Co Total Stockholders Equity?

Jiangxi Xinganjiang Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ¥473.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Jiangxi Xinganjiang Pharmaceutical Co's Book Value per Share for the quarter that ended in Dec. 2024 was ¥6.69. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Jiangxi Xinganjiang Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Dec. 2024 was 0.00.


Jiangxi Xinganjiang Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Jiangxi Xinganjiang Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Xinganjiang Pharmaceutical Co Total Stockholders Equity Chart

Jiangxi Xinganjiang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only 223.69 232.18 278.50 470.59 473.93

Jiangxi Xinganjiang Pharmaceutical Co Quarterly Data
Sep19 Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 470.59 484.22 477.56 482.30 473.93

Jiangxi Xinganjiang Pharmaceutical Co  (BJSE:873167) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Jiangxi Xinganjiang Pharmaceutical Co's Book Value per Share for the quarter that ended in Dec. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Jiangxi Xinganjiang Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Dec. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangxi Xinganjiang Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Jiangxi Xinganjiang Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangxi Xinganjiang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 36 Yunzhang Road, Jizhou District, Jiangxi Province, Ji'an City, CHN, 343000
Jiangxi Xinganjiang Pharmaceutical Co Ltd research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, Phenaminokamin Tablets.

Jiangxi Xinganjiang Pharmaceutical Co Headlines

No Headlines